Market Overview
Clinical Nutrition Market is growing at a CAGR of 8% during the forecast period 2024-2031.
Clinical nutrition product is a type of pharmaceutical product that helps to keep a patient healthy. It helps to improve the metabolic system by providing adequate supplements such as minerals, vitamins, and others. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements.
Market Scope
| Metrics | Details |
| Market CAGR | 8% |
| Segments Covered | By Product Type, By Formulation, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights about the Market Request Free Sample
Market Dynamics
The global clinical nutrition market growth is driven by the rising cases of metabolic and chronic diseases, unhealthy dietary habits leading to malnourishment, the surge in the geriatric population, the increasing number of premature births, and the rise in the adoption of home healthcare model.
The increasing prevalence of metabolic disorders drives the market growth
Over the past decade, the prevalence of metabolic disorders has increased. According to the Global Coalition on Aging study, in November 2020, the prevalence of malnutrition in hospitalized patients was around 31%. According to the Global Surgery Foundation, nearly 30% of worldwide diseases can be treated with surgery and require the direct care of a surgeon. During surgeries, clinical nutrition plays a major part in minimizing any adverse consequences to patients and enabling surgeons to work in a controlled environment. Thus, with the rising burden of diseases and the volume of surgeries, the clinical nutrition market is expected to boost during the forecast period.
As per the World Ageing Population Report, in 2020, about 727 million people worldwide were aged 65 years and above. This number is further expected to reach 1.5 billion by 2050. The elderly population is often susceptible to acquiring chronic diseases, leading to surgeries. In July 2020, Goodmills Innovation introduced ''Spermidino EVO'', a wheat germ concentrate specifically developed for immunity-boosting in the aging population. Hence, the growing number of the elderly population and the development of clinical nutrition products specific to the aging population are expected to drive market growth in the forecast period.
The lack of awareness especially in emerging countries will hamper the growth of the market
However, lack of awareness especially in emerging countries, and stringent government regulations are a few of the restraints that may result in lower adoption of alternate means of nutrition. The clinical nutrition market growth can be affected in the least developed regions of the world with comparatively lower standards of living attributed to the refusal of rationalized means to consume nutrition and, lack of acceptance of newer approaches. These factors will hamper the growth of the market in the forecast period.
COVID-19 Impact on Market
COVID-19 infection has become a major public health concern, and clinical nutrition plays a crucial role in preventing infection and treating infection-associated malnutrition. For instance, the European Society for Clinical Nutrition and Metabolism issued guidelines related to nutritional management in ICU patients infected with COVID-19. Thus, a positive impact can be expected on the market studied due to COVID-19.
People suffering from metabolic disorders such as diabetes are at high risk of acquiring COVID-19 infection. According to the International Diabetes Federation, people with pre-existing medical conditions such as diabetes and obesity are more prone to be infected with the SARS-CoV-2 virus due to compromised immune systems in these individuals. Treating diabetic patients infected with COVID-19 would be difficult as the virus tends to grow immensely in elevated blood sugar levels. Controlling blood sugar levels is of utmost importance in treating COVID-19-infected patients.
Market Segmentation Analysis
The infant nutrition segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)
Good nutrition during the first 2 years of life is vital for healthy growth and development. Starting good nutrition practices early can help children develop healthy dietary patterns. Infants are usually ready to eat solid foods at about 6 months of age. Although every infant and child has the right to good nutrition under the Convention on the Rights of the Child, in many countries less than a fourth of infants have access to the required dietary diversity and feeding frequency. Inappropriate feeding practices contribute to up to a third of all cases of child malnutrition. This is compounded by the proliferation of processed foods like infant formula and products rich in salt, free sugars, and trans fats. This causes an increase in poor diets, obesity, and a marked reduction in the number of mothers breastfeeding their babies. An organization such as WHO continues to work with the Member States and partners to promote proper infant and child nutrition, including breastfeeding information campaigns and efforts to prevent malnutrition at the local, national, and international levels.
Market Geographical Share
The North American region holds the largest market share of the global clinical nutrition market
The North American region is expected to dominate the clinical nutrition market. Some of the primary factors attributing to the growth of the clinical nutrition market include an increase in the prevalence of metabolic disorders and a rise in the geriatric population. According to the Centers for Disease Control and Prevention, the obesity rate among the US population was estimated to be around 42.4% in 2017-2018. As per the Centers for Disease Control and Prevention statistics, cancer and cardiovascular diseases are among the major burdens of the US healthcare sector.
According to the national diabetic statistic report in 2022 by the Centers for Disease Control and Prevention (CDC), around 37.3 million people suffered from diabetes in the U.S., accounting for 11.3% of the total U.S. population. Nutrition holds great significance in controlling metabolic diseases. Clinical nutrition such as monosaturated fat and fiber is administered to patients through Jejunal feeding in instances of patchy bowel dysmotility or symptomatic gastric atony observed in diabetic patients with autonomic neuropathy. Hence, such instances indicate a rising demand for clinical nutrition products, thereby driving the market growth.
Companies and Competitive Landscape
The clinical nutrition market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Abbott Laboratories (Abbott Nutrition), Nestle Health Science, Baxter Healthcare, B. Braun Melsungen AG, Danone (Nutricia), BASF SE, Perrigo Company PLC, Fresenius Kabi, Royal DSM, AYMES International Ltd among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the clinical nutrition market globally. For instance, in August 2021, Esperer Nutrition launched a range of consumer nutraceuticals for bone and joint health, immunity, urinary tract health, sleep apnea, and pre-diabetic care.
Baxter International Inc. - Overview
- Baxter International Inc.. is an American multinational healthcare company providing various healthcare products.
- From the first commercially produced intravenous solutions to leading acute, nutritional, renal, and surgical care innovations, they are committed to providing leading healthcare solutions.
- Their portfolio of acute, nutritional, renal, hospital, and surgical care products helps advance healthcare around the world.
- The company’s product and service offerings include dialysis in acute and chronic conditions, sterile intravenous solutions, generic injectable pharmaceuticals, parenteral nutrition therapies, infusion systems, and devices, inhaled anesthetics, and surgical hemostat and sealant products.
- The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific.
Abbott Laboratories
Overview:
Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of healthcare products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
Product Portfolio:
ENSURE PRE-SURGERY: ENSURE PRE-SURGERY is a clear carbohydrate beverage specially designed to improve general well-being both before and after surgery. Designed to be consumed up to 2 hours before anesthesia/surgery.
